Ratnakar Securities Pvt. Ltd.

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE426.05-6.95 (-1.61 %)

PREV CLOSE ( ) 433.00

OPEN PRICE ( ) 430.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3486

TODAY'S LOW / HIGH ( )426.05 435.00

52 WK LOW / HIGH ( )265.5 490

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992

Management Info

- Chairman Mukund P Mehta - Managing Director

Registered Office

Address C 301/2 M I D C,T T C Industrial Area,Pawane Village,
Navi Mumbai,
Maharashtra-400705

Phone 022-62996300

Email info@kilitch.com

Website www.kilitch.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

14Jul Board Meeting Outcome for Outcome Of
Board meeting to approve issue period and letter of offer

09Jul Allotment of Rights Shares
Inter alia, considered and approved the following terms of the Rights Is..

04Feb Kilitch Drugs (India) informs about pr
Kilitch Drugs (India) has informed that it enclosed its Press Release re..

22Jan Kilitch Drugs makes additional investm
Kilitch Drugs (India) has made additional investment of $2,00,000 to acq..

22Jan Kilitch Drugs surges on making additio
Kilitch Drugs (India) is currently trading at Rs. 339.20, up by 2.20 poi..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	113.73	311.57
Gross Profit	149.98	406.9
Operating Profit	162.3	445.53
Net Sales	563.04	1815.87

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 13792.95 (0.71%)	M.Cap ( in Cr)17696.20
Ipca Laboratories (BSE) 1541.65 (5.44%)	M.Cap ( in Cr)39112.31
Ajanta Pharma (BSE) 2794.85 (2.87%)	M.Cap ( in Cr)34911.06
Senores Pharmaceutic (BSE) 678.65 (11.30%)	M.Cap ( in Cr)3125.43
Astrazeneca Pharma I (BSE) 9021.20 (0.76%)	M.Cap ( in Cr)22553.00

Shareholding Pattern

	PROMOTERS	69.23%
	NON-INSTITUTION	30.76%
	FI/BANKS/INSURANCE	0%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

KILITCH DRUGS (INDIA) LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES